Pupil dilation to tropicamide is not specific for Alzheimer disease

Archives of Neurology

Volumn 54, Issue 7, 1997, Pages 841-844

  Growdon, John H ^a   Graefe, Karin ^a   Tennis, Marsha ^a   Hayden, Doug ^a   Schoenfeld, David ^a   Wray, Shirley H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; TROPICAMIDE;

AGED; ALZHEIMER DISEASE; ANISOCORIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; PRIORITY JOURNAL; PUPIL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0030851211     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550190031011     Document Type: Article

References (14)

1. Scinto LF, Daffner KR, Dressier D, et al. A potential noninvasive neurobiological test for Alzheimer's disease. Science. 1994;266:1051-1054.
2. Aral H, Terajima M, Nakagawa T, Higuchi S, Mochizuki H, Sasaki H. Pupil dilatation assay by tropicamide is modulated by apohpoprotem E e4 allele dosage in Alzheimer's disease. Neuroreport. 1996;7:918-920.
3. Loupe DN, Newman NJ, Green RC, et al. Pupillary response to tropicamide in patients with Alzheimer's disease. Ophthalmology. 1996;103:495-503.
4. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
5. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
6. Locascio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol. 1995;52:1087-1099.
7. McKusick VA. Mechanisms in genetic diseases of man. Am J Med. 1957;22:676-686.
8. Berg JM, Brandon MWG, Kirman BH. Atropine in mongolism. Lancet 1959;2:441-442.
9. O'Brien D, Haake MW, Braid B. Atropine sensitivity and serotonin in mongolism. AJDC. 1960;100:873-874.
10. Priest JH. Atropine response of the eyes in mongolism. AJDC. 1960;100:869-872.
11. Sacks B, Smith S. People with Down's syndrome can be distinguished on the basis of cholinergic dysfunction. J Neurol Neurosurg Psychiatry. 1989;52:1294-1295.
12. Olson MI, Shaw C-M. Presenile dementia and Alzheimer's disease in mongolism. Brain. 1969;92:147-156.
13. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984;122:1131-1135.
14. Potter H. Review and hypothesis: Alzheimer disease and Down syndrome: chromosome 21 nondisjunction may underlie both disorders. Am J Hum Genet 1991;48:192-1200.